1,436
Views
4
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

Novel methods for nucleotide length control in double-stranded polyinosinic-polycytidylic acid production using uneven length components

ORCID Icon, ORCID Icon, , &
Pages 1889-1901 | Received 27 Apr 2018, Accepted 08 Jul 2018, Published online: 05 Aug 2018

References

  • Chamberlin MJ, Patterson DL. Physical and chemical characterization of the ordered complexes formed between polyinosinic acid, polycytidylic acid and their deoxyribo-analogues. J Mol Biol. 1965;12:410–428.
  • Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006;7(2):131–137.
  • Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev. 2009;227(1):75–86.
  • Watanabe A, Tatematsu M, Saeki K, et al Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation. J Biol Chem. 2011;286(12):10702–10711.
  • Kato H, Takeuchi O, Sato S, et al Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441(7089):101–105.
  • Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13(5):816–825.
  • Seya T, Shime H, Takaki H, et al TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis. OncoImmunol. 2012;1(6):917–923.
  • Hilleman MR, Lampson GP, Tytell AA, et al. Double-stranded RNAs in relation to interferon induction and adjuvant activity. In: Beers RF, Braun W, editors. Biological effects of polynucleotides. New York: Springer-Verlag; 1971. p. 27–44.
  • Hamilton LD. Immunogenic polynucleotides. In: Beers RF, Braun W, editors. Biological effects of polynucleotides. New York: Springer-Verlag; 1971. p. 107–128.
  • Ichinohe T, Watanabe I, Ito S, et al Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J Virol. 2005;79(5):2910–2919.
  • Ichinohe T, Ainai A, Ami Y, et al Intranasal administration of adjuvant-combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus. J Med Virol. 2010;82(10):1754–1761.
  • Perez-Giron JV, Belicha-Villanueva A, Hassan E, et al Mucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity. J Immunol. 2014;193(3):1324–1332.
  • Phoolcharoen W, Dye JM, Kilbourne J, et al A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. Proc Natl Acad Sci U S A. 2011;108(51):20695–20700.
  • Forte G, Rega A, Morello S, et al Polyinosinic-polycytidylic acid limits tumor outgrowth in a mouse model of metastatic lung cancer. J Immunol. 2012;188(11):5357–5364.
  • Seya T, Azuma M, Matsumoto M. Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer. Exp Op Ther Tar. 2013;17(5):533–544.
  • Galli R, Paone A, Fabbri M, et al Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARbeta and tumor regression. Proc Natl Acad Sci U S A. 2013;110(24):9812–9817.
  • Nagato T, Lee YR, Harabuchi Y, et al Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumors. Clin Cancer Res. 2014;20(5):1223–1234.
  • Ammi R, De Waele J, Willemen Y, et al Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs. Pharmacol Ther. 2015;146:120–131.
  • Forghani P, Waller EK. Poly (I:C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer. Breast Cancer Res Treat. 2015;153(1):21–30.
  • Gesuete R, Packard AE, Vartanian KB, et al Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling. J Neurochem. 2012;123 Suppl 2:75–85.
  • Wang PF, Fang H, Chen J, et al Polyinosinic-polycytidylic acid has therapeutic effects against cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via TLR3. J Immunol. 2014;192(10):4783–4794.
  • Harris P, Sridhar S, Peng R, et al Double-stranded RNA induces molecular and inflammatory signatures that are directly relevant to COPD. Mucosal Immunol. 2013;6(3):474–484.
  • Kimura G, Ueda K, Eto S, et al Toll-like receptor 3 stimulation causes corticosteroid-refractory airway neutrophilia and hyperresponsiveness in mice. Chest. 2013;144(1):99–105.
  • Qu WM, Miyazaki T, Terada M, et al A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic: polycytidylicacid. Clin Exp Immunol. 2002;129(1):27–34.
  • Field R, Campion S, Warren C, et al Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun. 2010;24(6):996–1007.
  • Aavani T, Rana SA, Hawkes R, et al Maternal immune activation produces cerebellar hyperplasia and alterations in motor and social behaviors in male and female mice. Cerebellum. 2015;14(5):491–505.
  • Ginzel M, Yu Y, Klemann C, et al The viral dsRNA analogue poly (I:C) induces necrotizing enterocolitis in neonatal mice. Pediatr Res. 2016;79(4):596–602.
  • Wright RJ, Visness CM, Calatroni A, et al Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort. Am J Respir Crit Care Med. 2010;182(1):25–33.
  • Wang B, Koga K, Osuga Y, et al Toll-like receptor-3 ligation-induced indoleamine 2, 3-dioxygenase expression in human trophoblasts. Endocrinology. 2011;152(12):4984–4992.
  • Dauletbaev N, Cammisano M, Herscovitch K, et al Stimulation of the RIG-I/MAVS pathway by polyinosinic: polycytidylicacid upregulates IFN-beta in airway epithelial cells with minimal costimulation of IL-8. J Immunol. 2015;195(6):2829–2841.
  • Lampson GP, Field AK, Tytell AA, et al Relationship of molecular size of rIn: rCn(poly I:C) to induction of interferon and host resistance. Proc Soc Exp Biol Med. 1970;135(3):911–916.
  • Machida H, Kuninaka A, Yoshino H. Relationship between the molecular size of poly I-poly C and its biological activity. Jpn J Microbiol. 1976;20(2):71–76.
  • Studier FW. Sedimentation studies of the size and shape of DNA. J Mol Biol. 1965;11:373–390.
  • Yano J, Oki T Nucleic acid derivative. JP 63-146233A1. 1988.
  • de Clercq E. Degradation of poly(inosinic acid) - poly(cytidylic acid) [(I)n - (C)n] by human plasma. Eur J Biochem. 1979;93(1):165–172.
  • Liu L, Botos I, Wang Y, et al Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science. 2008;320(5874):379–381.
  • Luo J, Obmolova G, Malia TJ, et al Lateral clustering of TLR3: dsRNAsignaling units revealed by TLR3ecd:3Fabs quaternary structure. J Mol Biol. 2012;421(1):112–124.
  • Kato H, Takeuchi O, Mikamo-Satoh E, et al Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med. 2008;205(7):1601–1610.
  • Basilio C, Ochoa S. Enzymatic synthesis of polyribonucleotides. Methods Enzymol. 1963;6:713–718.
  • Gillam S, Smith M. Use of E. coli polynucleotide phosphorylase for the synthesis of oligodeoxyribonucleotides of defined sequence. Methods Enzymol. 1980;65(1):687–701.
  • Field AK, Tytell AA, Lampson GP, et al Inducers of interferon and host resistance, II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci U S A. 1967;58:1004–1010.
  • Torrence PF. Preparation of a synthetic polynucleotide interferon inducer. Methods Enzymol. 1981;78(Pt A):326–331.
  • WHO guidelines on the nonclinical evaluation of vaccine adjuvants and adjuvanted vaccines. WHO expert committee on biological standardization. Sixty-fourth report. Geneva: World Health Organization; 2014. p. 59–100.
  • Kato Y, Yamasaki Y, Onaka A, et al Separation of DNA restriction fragments by high-performance ion-exchange chromatography on a non-porous ion exchanger. J Chromatogr. 1989;478:264–268.
  • Michelson AM, Massoulié J, Guschlbauer W. Synthetic polynucleotides. Prog Nucleic Acid Res Mol Biol. 1967;6:83–141.
  • Bloomfield VA, Crothers DM, Ignacio Tinoco J. Electonic and vibrational spectroscopy. Nucleic acids: structures, properties, and functions. Sausalito: University Science Books; 2000. p. 165–222.
  • Billiau A, Edy VG, Heremans H, et al Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother. 1977;12(1):11–15.
  • Li Y, Breaker RR. Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2ʹ-hydroxyl group. J Am Chem Soc. 1999;121(23):5364–5372.
  • Sarkar PK, Yang JT. Optical activity and the conformation of polyinosinic acid and several other polynucleotide complexes. Biochemistry. 1965;4(7):1238–1244.
  • de Clercq E. Synthetic interferon inducers. Top Curr Chem. 1974;52:173–208.
  • Machida H, Kuninaka A, Yoshino H. Effect of nucleosides on interferon production and development of antiviral state induced by poly I.poly C. Microbiol Immunol. 1979;23(7):643–650.
  • Merigan TC, De Clercq E, Eckstain F, et al. Molecular requirements for synthetic RNA to act in interferon stimulation. In: Beer RFJ, Braun W, editors. Biological effects of polynucleotides. New York, NY: Springer; 1971. p. 67–78.
  • Wolfenden R. Benchmark reaction rates, the stability of biological molecules in water, and the evolution of catalytic power in enzymes. Annu Rev Biochem. 2011;80:645–667.
  • Okahira S, Nishikawa F, Nishikawa S, et al Interferon-β induction through toll-like receptor 3 depends on double-stranded RNA structure. DNA Cell Biol. 2005;24(10):614–623.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.